{
  "pmcid": "11490177",
  "sha256": "f82873c0c078128cf8a2ebdf8eacae0c7ac715e85cf34a714ae92f9b294afe71",
  "timestamp_utc": "2025-11-09T23:16:47.677969+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.156355212355212,
    "reading_ease": 9.98346460746464,
    "word_count": 259
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Tranexamic Acid in Major Abdominal Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "multicenter, double-blind, placebo-controlled, randomised superiority trial involves 850 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "850 patients aged 18 years or older undergoing elective esophagectomy, gastrectomy, colectomy, rectal resection, pancreatic resection, or hepatectomy across eleven academic hospitals in Germany"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive either TXA (1000 mg bolus before incision, 125 mg/h until closure) or placebo"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome is the need for transfusion of at least one unit of PRBCs, measured intra- or postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation is computer-generated with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding includes patients, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Recruitment began on June 17, 2024, with completion expected by November 2025."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis will follow an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events will be monitored"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "trial registration EU CT Nr: 2023–509970-43–01, NCT06414031"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding is provided by institutional grants."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}